Mounjaro is made by Eli Lilly and Company , a large American pharmaceutical manufacturer based in Indianapolis, Indiana.

Quick Scoop

  • Mounjaro (tirzepatide) is developed and manufactured by Eli Lilly and Company.
  • Lilly markets Mounjaro globally for type 2 diabetes and, in many places, for weight management as well.
  • The drug and its injection device are registered trademarks owned or licensed by Eli Lilly and its subsidiaries.

Who makes Mounjaro?

Eli Lilly and Company, often branded simply as Lilly, is the company behind Mounjaro. It is a long‑established U.S. pharma company whose products are sold in over 100 countries, and it also produces other metabolic and obesity‑related medicines.

Mounjaro itself is a once‑weekly injectable medicine whose active ingredient is tirzepatide, a dual GIP/GLP‑1 receptor agonist used to help control blood sugar and support weight loss. In markets such as the UK and EU, Lilly is listed as the marketing authorization holder and manufacturer for Mounjaro.

A bit of current context

  • In Europe and the UK, health regulators have approved Mounjaro for adults with type 2 diabetes, and in some cases for weight management in people with obesity or weight‑related health issues.
  • There has been recent news about price changes in places like the UK, where Eli Lilly has adjusted Mounjaro’s price to align more closely with other developed markets.

Forum‑style note

Many forum discussions asking “who makes Mounjaro?” are really people checking if it’s linked to a big, established pharma player or a smaller startup. In this case, it’s one of the largest legacy companies in the sector: Eli Lilly and Company.

TL;DR: Mounjaro (tirzepatide) is manufactured and marketed by the multinational pharmaceutical company Eli Lilly and Company.

Information gathered from public forums or data available on the internet and portrayed here.